Leqembi-Iqlik PDUFA Date Updated To August 24 In US
09 May 2026 //
PR NEWSWIRE
Atara, Pierre`s Cell Therapy to Get Another Shot at FDA Approval
09 May 2026 //
BIOSPACE
GSK Licenses Halozyme ENHANZE for Subcutaneous Cancer Drugs
09 May 2026 //
PR NEWSWIRE
EnGene`s Shares Crash On Updated Pivotal Bladder Cancer Data
09 May 2026 //
ENDPOINTS
Immunai and AstraZeneca Expand AI-Driven Biomarker Project
09 May 2026 //
AI JOURNAL
Neuland, LIR Partner to Advance Cell Penetrating Peptide Platform
09 May 2026 //
EXPRESSPHARMA
FDA Approves Ocrevus for Pediatric Relapsing-Remitting MS
09 May 2026 //
FIRSTWORD PHARMA
BMS Wins EU Approval for Sotyktu in Active Psoriatic Arthritis
09 May 2026 //
PHARMIWEB
Alpha Tau Fills Pivotal Skin Cancer Trial, Eyes FDA DaRT Approval
09 May 2026 //
GLOBENEWSWIRE
Drugs In Development
Market Intel

Market Place
Sourcing Support